For patients of T3 N0, 1 M0 NSCLC involving the chest wall, which of the following is the preferred primary therapeutic modality

January 11, 2022

1 View

For patients of T3 N0, 1 M0 NSCLC involving the chest wall, which of the following is the preferred primary therapeutic modality

Q. For patients of T3 N0, 1 M0 NSCLC involving the chest wall, which of the following is the preferred primary therapeutic modality :

A. Surgery

B. Radiation alone

C. Chemoradiation

D. None of the above

Answer: surgery

For patients of T3 N0, 1 M0 NSCLC involving the chest wall, which of the following is the preferred primary therapeutic modality

Previous

Bank Of Baroda Recruitment 2022 – 47 Agriculture Marketing Officer Vacancy

For patients of T3 N0, 1 M0 NSCLC involving the chest wall, which of the following is the preferred primary therapeutic modality

Next

If a patient is suspected of having N0/N1 disease but intraoperatively is found to be having N2 disease, the so called incidental N2 disease; then which of the following will be the best course of treatment :

Related Articles

What is the most common type of bladder cancer?

What is the most common type of bladder cancer?

All of the below are symptoms of advanced bladder cancer except which one?

All of the below are symptoms of advanced bladder cancer except which one?

True or false? Bladder cancer affects mostly young women

True or false? Bladder cancer affects mostly young women

Which region in the u.s. Has the highest incidence rate of bladder cancer?

Which region in the u.s. Has the highest incidence rate of bladder cancer?

We will be happy to hear your thoughts

Leave a reply Cancel reply

You must be logged in to post a comment.